在针对该物质采取进一步行动之前，注册人是否可以与 ECHA 进行面对面会议，或以其他方式澄清小组评估中的某些问题？是否可以向 ECHA 发送更多信息？

在针对该物质采取进一步行动之前，注册人是否可以与 ECHA 进行面对面会议，或以其他方式澄清小组评估中的某些问题？是否可以向 ECHA 发送更多信息？

Is it possible for the registrants to have a face-to-face meeting with ECHA or otherwise clarify some issue in the group assessment before further actions are initiated on the substance? Is it possible to send additional information to ECHA?

在评估物质组的监管需求时，欧洲化学品管理局 (ECHA) 预计不会与注册人直接互动。我们强烈建议注册人尽快主动更新其注册中的危害、用途和数量信息，最好在计划的监管行动开始之前进行。ECHA 将在后续正式流程以及更新监管需求评估时考虑更新中提供的信息。如有其他疑问，我们建议联系 ECHA。一旦发布了物质组的监管需求评估，我们鼓励注册人咨询该评估，并考虑已发现的问题（如有）以及拟议的后续步骤。每当启动针对某种物质的正式流程时，我们都会在其网站上提供相关信息以及启动该行动的机构的联系方式。我们也鼓励业界参与不同监管流程中预期的磋商。

In the context of the assessments of regulatory needs of groups of substances, ECHA does not foresee direct interaction with the registrants. We highly recommend that registrants update their registrations proactively on hazards, uses and volumes information as soon as possible and preferably before the planned regulatory actions would start. The information provided in the update will be taken into account by ECHA in the following formal processes and when updating the assessment of regulatory needs. In case of additional questions we would recommend to contact ECHA. Once an assessment of regulatory needs for a group of substances is published, we encourage registrants to consult them and to consider the concern identified (if any) and the proposed next steps.  Whenever a formal process is initiated on a substance, the information is available on our website, along with the contact details of the authority initiating the action. We also encourage industry to contribute to the consultations foreseen in the different regulatory processes.